The bright and the dark sides of activin in wound healing and cancer

Journal of Cell Science, Sep 2012

Maria Antsiferova, Sabine Werner

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://jcs.biologists.org/content/125/17/3929.full.pdf

The bright and the dark sides of activin in wound healing and cancer

Maria Antsiferova ( 0 Sabine Werner ) 0 0 Department of Biology, Institute of Molecular Health Sciences , ETH Honggerberg, HPL E12, 8093, Zurich , Switzerland - Summary Activin was initially described as a protein that stimulates release of follicle stimulating hormone from the pituitary, and it is well known for its important roles in different reproductive functions. In recent years, this multifunctional factor has attracted the attention of researchers in other fields, as new functions of activin in angiogenesis, inflammation, immunity, fibrosis and cancer have been discovered. Studies from our laboratory have identified activin as a crucial regulator of wound healing and skin carcinogenesis. On the one hand, it strongly accelerates the healing process of skin wounds but, on the other hand, it enhances scar formation and the susceptibility to skin tumorigenesis. Finally, results from several laboratories have revealed that activin enhances tumour formation and/ or progression in some other organs, in particular through its effect on the tumour microenvironment, and that it also promotes cancerinduced bone disruption and muscle wasting. These findings provide the basis for the use of activin or its downstream targets for the improvement of impaired wound healing, and of activin antagonists for the prevention and treatment of fibrosis and of malignant e tumours that overexpress activin. Here, we summarize the previously described roles of activin in wound healing and scar formation and cn discuss functional studies that revealed different functions of activin in the pathogenesis of cancer. The relevance of these findings for ie clinical applications will be highlighted. c S ll Key words: Activin, Cancer, Tumour microenvironment, Wound healing e C f o l an Introduction contacts and start expressing mesenchymal markers such as ru In 1863, Rudolf Virchow had already recognized that chronic vimentin. Furthermore, matrix metalloproteinases and other Jo irritation and inflammatory hyperplasia are predispositions for proteolytic enzymes that are produced by epithelial and stromal cancer development (Virchow, 1863). A century later, Alexander cells are involved in the breakdown of extracellular matrix, which Haddow suggested that tumour production is a possible is essential for the migration of the cells at the wound edge, and overhealing (Haddow, 1974). Finally, Harold Dvorak postulated also for increased cancer cell motility and invasion (reviewed by that tumors are wounds that do not heal (Dvorak, 1986). These Arnoux et al., 2005). observations suggested that common cellular and molecular Besides the similar behaviour of epithelial cells during wound mechanisms are active in wounds and in cancer, and this concept healing and cancerogenesis, many similarities have also been has been strongly supported during subsequent years by various found in the stroma of healing wounds and carcinomas. These experimental studies. include similarities in the cellular composition and also in the A hallmark of wounds and of carcinomas (cancer of epithelial deposited extracellular matrix. Examples of the matrix alterations cells) is the enhanced proliferation and migration of epithelial that are seen in wounds and in tumours are differences in collagen cells. In healing wounds, this allows efficient re-epithelialization remodeling compared with that in normal tissues, and upregulation of the injured body site and it is terminated when the wound is fully of various extracellular matrix molecules, such as tenascin-C and covered by a new epidermis. In a carcinoma, however, this process an embryonic splice variant of fibronectin. Furthermore, is not self-limiting and results in unlimited tumour growth and fibrinogen is released from injured vessels upon wounding or eventually metastasis (reviewed by Schafer and Werner, 2008). from chronically hyperpermeable vessels in tumours (reviewed by During cutaneous wound repair, keratinocytes at the wound edge Werner and Grose, 2003; Egeblad et al., 2010). It is subsequently lose their cellcell contacts, rearrange their actin cytoskeleton and cleaved by thrombin to form fibrin, which polymerizes to form a express various proteases to degrade the basement membrane and clot. This matrix provides a favourable substrate that promotes cell interstitial connective tissue. These events are reminiscent of the migration and proliferation (Dvorak, 1986). epithelialmesenchymal transition (EMT) that occurs during Inflammation is a central event in wound repair that protects development and is also frequently seen in advanced-stage the host from infection, as inflammatory cells release reactive carcinomas. However, in skin wounds EMT is only partial and oxygen species and proteases to defend bacteria. Furthermore, reversible keratinocytes retain some intercellular contacts and inflammatory cells are potent sources of various growth factors continue to express epidermal keratins (reviewed by Schafer a (...truncated)


This is a preview of a remote PDF: https://jcs.biologists.org/content/125/17/3929.full.pdf

Maria Antsiferova, Sabine Werner. The bright and the dark sides of activin in wound healing and cancer, Journal of Cell Science, 2012, pp. 3929-3937, 125/17, DOI: 10.1242/jcs.094789